Nuveen Asset Management, LLC Forma Therapeutics Holdings, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $95,820 - $272,389	-13,458 Reduced 6.28%	200,901 $4.01 Million
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $467,236 - $916,150	91,615 Added 74.64%	214,359 $1.48 Million
Q1 2022 May 16, 2022	BUY	$8.34 - $14.69 $10,766 - $18,964	1,291 Added 1.06%	122,744 $1.15 Million
Q4 2021 Feb 14, 2022	SELL	$13.6 - $24.89 $103,183 - $188,840	-7,587 Reduced 5.88%	121,453 $1.59 Million
Q3 2021 Nov 12, 2021	SELL	$21.22 - $25.7 $250,162 - $302,977	-11,789 Reduced 8.37%	129,040 $3.06 Million
Q2 2021 Aug 16, 2021	BUY	$22.86 - $30.95 $183,451 - $248,373	8,025 Added 6.04%	140,829 $3.51 Million
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $1.68 Million - $2.92 Million	68,232 Added 105.67%	132,804 $3.72 Million
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $75,000 - $109,770	2,149 Added 3.44%	64,572 $2.25 Million
Q3 2020 Nov 16, 2020	BUY	$32.95 - $50.25 $2.06 Million - $3.14 Million	62,423 New	62,423 $3.11 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.